welcome to DuchenneXchange

- a positively charged Duchenne muscular dystrophy community.
  • join today!

Sunphenon Epigallocatechin-Gallate (EGCg) in Duchenne Muscular Dystrophy

key information

study id #: NCT01183767

condition: Duchenne Muscular Dystrophy

status: completed


The aim of this multicentre, prospective, double blind, placebo controlled, randomized pilot study is to investigate safety and tolerance of Epigallocatechin-Gallate (EGCG, the major polyphenol in green tea) in patients with muscular dystrophy of the Duchenne type. In a second step the investigators want to investigate the effect of EGCG on the course of the Duchenne condition.

intervention: Epigallocatechin-Gallate, Placebo

mechanism of action: Major plyphenal in green tea for neuroprotective benefits

results: https://clinicaltrials.gov/ct2/show/results/NCT01183767

last updated: April 19, 2020